Use of human beta interferon for the production of pharmaceutical compositions for the treatment of chronic myeloid leukaemia

摘要

Interferon-beta, preferably in low doses, is used for stimulation of erythropoiesis in disorders characterized by lack of maturation of progenitor blood cells to red cells.